GenSight Biologics Appoints Barrett Katz as Chief Medical Officer

GenSight Biologics Appoints Barrett Katz as Chief Medical Officer

GenSight Biologics , a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system , announced it has appointed Barrett Katz, M.D., M.B.A., as Chief Medical Officer, effective November 1, 2017. Dr. Katz replaces Mohamed Genead, M.D., who resigned from the position for personal reasons.

from Biotech News